United States · FDA National Drug Code directory
Dapsone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82804-988_9cfe5fe7-abc7-4f48-a597-1b1a5c70a354
- Product NDC
- 82804-988
- Form
- TABLET
- Composition / generic term
- Dapsone
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240116
- Source listing expiry
- 20261231
Source-listed ingredients
- DAPSONE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (82804-988-00) · 82804-988-00
- 1000 TABLET in 1 BOTTLE (82804-988-11) · 82804-988-11
- 30 TABLET in 1 BOTTLE (82804-988-30) · 82804-988-30
- 500 TABLET in 1 BOTTLE (82804-988-55) · 82804-988-55
- 60 TABLET in 1 BOTTLE (82804-988-60) · 82804-988-60
- 240 TABLET in 1 BOTTLE (82804-988-64) · 82804-988-64
- 120 TABLET in 1 BOTTLE (82804-988-72) · 82804-988-72
- 180 TABLET in 1 BOTTLE (82804-988-78) · 82804-988-78
- 90 TABLET in 1 BOTTLE (82804-988-90) · 82804-988-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →